Director, Vice Chairman, Professor, Fox Chase Cancer Center,
Aims and Scope
Mathews Journal of Cancer Science (ISSN 2474-6797) — is an open access journal publishes original studies and reports, which provide significance and board impact on a wider audience. The main scope of the journal is in its primary sections of preclinical, clinical, epidemiological, treatments of different cancer, Cancer Biology, lymphoma, sarcoma, cancer genetics, cancer therapy, gynecologic cancer, brain tumor, malignant tumor, lung cancer, cancer prevention & epidemiology, oncogene study and benign tumors.
Editors and Editorial Board
Editorial process of cancer science journal and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Board and journal staff.
Mathews Journal of Cancer Science (MJCS) Print ISSN: 2474-6797 and Online ISSN: 2474-6797 is published Bimonthly, a Volume/year.
Benefits of authors
High Visibility: Mathews Journal of Cancer Science (MJCS) as per open access policy allows maximum visibility of articles published in the journal available across the globe.
Promotion in Social Media: Once the article is published, we provide article alerts and regular email updates to subscribers on our social media platforms.
Speed Publication: Mathews Journal of Cancer Science (MJCS) provides fast publication of the submitted articles with quality review process with the esteem editorial board team and reviewer’s team.
We welcome all type of articles related to cancer and oncology. For submission assistance contact: firstname.lastname@example.org or email@example.com. Please follow the Author Guidelines
If you are not sure whether your work suitable for this journal, please email us at firstname.lastname@example.org or call us at (Toll-Free) +1 800 369 0052.
Published : 12th December 2019
Authors : Zhitao Dai1, Cui Yang2,3, Wei Jiang1, Man Zhao1, Weigang Hu2,3, and Hua Ren1*
Citation : Ren H. (2019). The Impact of Normalization Isodose Line (NIDL) on Dose Distribution in Intracranial Tumors Treated with CyberKnife. Mathews J Cancer Sci. 4(2): 23.
Published : 11th December 2019
Author : Chang-Ming Charlie Ma
Citation : Ma CM. (2019). Physics and Dosimetric Principles of SRS and SBRT. Mathews J Cancer Sci. 4(2): 22
Published : 01st November 2019
Authors : Bin Wang1,2, Jianhua Ren3, Peng Zhang4, Dusica Cvetkovic1, Xiaoming Chen1, Lili Chen1, and Chang-Ming Charlie Ma1
Citation : Ma CM. (2019). An In-Vivo Study on Pulsed Low-Dose-Rate Radiotherapy for Prostate Cancer. Mathews J Cancer Sci. 4(2): 21.
Published : 17th June 2019
Authors : Reger R. Mikaeel1,2,3,4 , Timothy J. Price1,3, Eric Smith1,5, Paul A. Drew5, Wendy Uylaki1,6, Mehgan Horsnell1, Joanne P. Young1,2,3
Citation : Mikaeel RR. (2019). Colorectal Cancer in Australian Young Adults. Mathews J Cancer Sci. 4(1): 18
Published : 17th March 2019
Authors : Jiancang Wang*, Feifan Du, Ming Su, Xiting Guo, Haixia Tian, Yanxia Song, Liya shang, Wei Zheng, Xiaoge Yang
Citation : Wang J. (2019). Cytomegalovirus Retinitis in a 4-Year-Old Child with Acute Lymphoblastic Leukemia: Treatment and Prognosis. Mathews J Cancer Sci. 4(1): 17
Published : 30th November 2018
Authors : Yang Yang1,3, Olagoke Zacchaeus Olatunde2 , Jianping Yong1 *, Canzhong Lu1,2*
Citation : Yang Y, Olatunde OZ, Yong J and Lu C. (2018). Progress of Chemical Components and Biological Activities of Lonicera Maackii. Mathews J Cancer Sci. 3(1): 016.
Published : 12th November 2018
Authors : Mahdis Solhjoo1*,Alireza Rastgoo Haghi2,Nasim Golchin3,Negar Golchin4,Roham Shahbazi2
Citation : Solhjoo M, Haghi AR, Golchin N, Golchin N, et al. (2018). Expression of E-cadherin and Ki-67 in Gastric Cancer Patients and Cor- relation with Clinicopathological Factors.Mathews J Cancer Sci. 3(1): 015
Published : 18th September 2018
Author : Jussara Maria Gonçalves1 *
Citation : Gonçalves JM. (2018). Cancer Stem Cells: Current Challenge in Cancer Treatment and Important Prognosis Factor.Mathews J Cancer Sci. 3(1): e001
Published : 26th February 2018
Author : Dennis Stamp1*
Citation : Stamp D. (2018). Suggested Model to Induce Esophageal Cancer and Its Precursor Lesions in the Esophagus of Rats. Mathews J Cancer Sci. 3(1): 014.